Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy
(NASDAQ: ANIX) Delayed: 2.77 -0.14 (4.81%)
Previous Close $2.91    52 Week High $ 
Open $2.97    52 Week Low $ 
Day High $2.97    P/E N/A 
Day Low $2.75    EPS $ 
Volume 285,078